CN1579414A - 注射用灵孢多糖及其制备工艺 - Google Patents
注射用灵孢多糖及其制备工艺 Download PDFInfo
- Publication number
- CN1579414A CN1579414A CN 200410013601 CN200410013601A CN1579414A CN 1579414 A CN1579414 A CN 1579414A CN 200410013601 CN200410013601 CN 200410013601 CN 200410013601 A CN200410013601 A CN 200410013601A CN 1579414 A CN1579414 A CN 1579414A
- Authority
- CN
- China
- Prior art keywords
- ganoderma
- glossy
- spore
- spore polysaccharide
- amounts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002347 injection Methods 0.000 title claims abstract description 23
- 239000007924 injection Substances 0.000 title claims abstract description 23
- 150000004676 glycans Chemical class 0.000 title claims description 65
- 229920001282 polysaccharide Polymers 0.000 title claims description 65
- 239000005017 polysaccharide Substances 0.000 title claims description 65
- 238000002360 preparation method Methods 0.000 title claims description 15
- 239000000243 solution Substances 0.000 claims abstract description 30
- 239000000047 product Substances 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 15
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000005516 engineering process Methods 0.000 claims description 24
- 238000001035 drying Methods 0.000 claims description 22
- 240000008397 Ganoderma lucidum Species 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 239000012043 crude product Substances 0.000 claims description 12
- 238000001556 precipitation Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 241000222336 Ganoderma Species 0.000 claims description 11
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 108010019160 Pancreatin Proteins 0.000 claims description 6
- 230000001413 cellular effect Effects 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000004440 column chromatography Methods 0.000 claims description 6
- 238000005262 decarbonization Methods 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 229940055695 pancreatin Drugs 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 229920001503 Glucan Polymers 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- -1 filter Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 239000013067 intermediate product Substances 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 229920000856 Amylose Polymers 0.000 abstract 5
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 241000207961 Sesamum Species 0.000 abstract 1
- 238000004500 asepsis Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 25
- 230000000694 effects Effects 0.000 description 5
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 239000008227 sterile water for injection Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010068871 Myotonic dystrophy Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000028872 Progressive muscular dystrophy Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 208000005987 polymyositis Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410013601 CN1261104C (zh) | 2004-03-04 | 2004-03-04 | 注射用灵孢多糖及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410013601 CN1261104C (zh) | 2004-03-04 | 2004-03-04 | 注射用灵孢多糖及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1579414A true CN1579414A (zh) | 2005-02-16 |
CN1261104C CN1261104C (zh) | 2006-06-28 |
Family
ID=34581687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410013601 Expired - Lifetime CN1261104C (zh) | 2004-03-04 | 2004-03-04 | 注射用灵孢多糖及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1261104C (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101933610A (zh) * | 2010-07-23 | 2011-01-05 | 江苏安惠生物科技有限公司 | 一种食药用菌细胞组分的综合提取法及提取物的应用 |
CN102038650A (zh) * | 2009-10-16 | 2011-05-04 | 上海医药工业研究院 | 紫芝菌丝体多糖精制物冻干粉针剂及其制备方法 |
CN103550147A (zh) * | 2013-11-14 | 2014-02-05 | 福建农林大学 | 灵芝子实体多糖注射剂及其制备方法 |
CN103819574A (zh) * | 2014-03-07 | 2014-05-28 | 南开大学 | 一种从斑嗜蓝孢孔菌中提取的抗氧化多糖及其制备方法 |
JP2015110546A (ja) * | 2013-11-07 | 2015-06-18 | 日本メナード化粧品株式会社 | トランスポゾン移動抑制剤 |
CN106309469A (zh) * | 2015-07-09 | 2017-01-11 | 山西国润制药有限公司 | 一种灵孢多糖注射液的制备工艺 |
CN107397765A (zh) * | 2017-07-31 | 2017-11-28 | 广东省微生物研究所(广东省微生物分析检测中心) | 一种破壁灵芝孢子提取物及其提取方法和应用 |
-
2004
- 2004-03-04 CN CN 200410013601 patent/CN1261104C/zh not_active Expired - Lifetime
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102038650A (zh) * | 2009-10-16 | 2011-05-04 | 上海医药工业研究院 | 紫芝菌丝体多糖精制物冻干粉针剂及其制备方法 |
CN102038650B (zh) * | 2009-10-16 | 2014-06-04 | 上海医药工业研究院 | 紫芝菌丝体多糖精制物冻干粉针剂及其制备方法 |
CN101933610A (zh) * | 2010-07-23 | 2011-01-05 | 江苏安惠生物科技有限公司 | 一种食药用菌细胞组分的综合提取法及提取物的应用 |
JP2015110546A (ja) * | 2013-11-07 | 2015-06-18 | 日本メナード化粧品株式会社 | トランスポゾン移動抑制剤 |
CN103550147A (zh) * | 2013-11-14 | 2014-02-05 | 福建农林大学 | 灵芝子实体多糖注射剂及其制备方法 |
CN103550147B (zh) * | 2013-11-14 | 2015-11-18 | 福建农林大学 | 灵芝子实体多糖注射剂及其制备方法 |
CN103819574A (zh) * | 2014-03-07 | 2014-05-28 | 南开大学 | 一种从斑嗜蓝孢孔菌中提取的抗氧化多糖及其制备方法 |
CN103819574B (zh) * | 2014-03-07 | 2016-02-03 | 南开大学 | 一种从斑嗜蓝孢孔菌中提取的抗氧化多糖及其制备方法 |
CN106309469A (zh) * | 2015-07-09 | 2017-01-11 | 山西国润制药有限公司 | 一种灵孢多糖注射液的制备工艺 |
CN107397765A (zh) * | 2017-07-31 | 2017-11-28 | 广东省微生物研究所(广东省微生物分析检测中心) | 一种破壁灵芝孢子提取物及其提取方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1261104C (zh) | 2006-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103768534B (zh) | 一种具有抗肿瘤活性的中药组合物 | |
CN1261104C (zh) | 注射用灵孢多糖及其制备工艺 | |
CN105504085B (zh) | 蛹虫草葡聚糖及其制备方法和应用 | |
CN1142155C (zh) | 蛇葡萄素在制备抗白血病和抗鼻咽癌药物中的应用 | |
CN108310002B (zh) | 一种预防和/或治疗血管损伤疾病的组合物及其用途 | |
CN1817354A (zh) | 辛芪注射剂及制备方法 | |
CN102626427B (zh) | 一种银杏达莫组合物及其制剂的制备方法 | |
CN1087275A (zh) | 治疗缺血性脑、心血管制剂舒脉宁 | |
CN102716231B (zh) | 一种治疗脑损伤和脑水肿的中药组合物及其应用 | |
CN106581109A (zh) | 一种用于治疗脑血栓的药物组合物 | |
CN100525759C (zh) | 一种用于治疗缺血性脑血管疾病的中成药 | |
CN1850149A (zh) | 一种黄芪提取物与香菇多糖组成的复方制剂及其制备方法 | |
CN1234370C (zh) | 一种治疗心血管疾病和休克急救的中药注射剂 | |
CN1935183A (zh) | 一种中药复方制剂及其制备方法 | |
CN1795927A (zh) | 红花总黄酮磷脂复合物及其制备方法 | |
CN1762417A (zh) | 治疗心脑血管疾病的复方黄芪制剂及其制备方法和其用途 | |
CN1939390A (zh) | 一种药物组合物及其制备方法 | |
CN1947763A (zh) | 一种心脏病治疗药物及其制备方法 | |
CN1762375A (zh) | 灯盏细辛酮酯及其注射剂的制备方法 | |
CN1270699C (zh) | 注射用生脉及其制备方法 | |
CN1596936A (zh) | 一种治疗癌症的中药制剂及其制备方法 | |
CN103127309B (zh) | 一种治疗心肌缺血的药物组合物八味沉香滴丸及其制备方法 | |
CN1939389A (zh) | 一种中药复方制剂及其制备方法 | |
CN108543003A (zh) | 抗癌中草药为原料的温经消积药物组合物 | |
CN101879157A (zh) | 山奈酚的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Heilongjiang Jiang Shi Pharmaceutical Co.,Ltd. Assignor: Jiang Weishi Contract fulfillment period: 2008.8.18 to 2018.8.18 Contract record no.: 2008230000028 Denomination of invention: Glossy-ganoderma-spore polysaccharide for injection and its preparation process Granted publication date: 20060628 License type: Exclusive license Record date: 20081009 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.8.18 TO 2018.8.18; CHANGE OF CONTRACT Name of requester: HEILONGJIANG JIANGSHI PHARMACEUTICAL CO., LTD. Effective date: 20081009 |
|
ASS | Succession or assignment of patent right |
Owner name: JIANG XIN Free format text: FORMER OWNER: JIANG WEISHI Effective date: 20110607 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110607 Address after: 150069 No. 2 Weihai Road, cottage economic and Technological Development Zone, Harbin, Heilongjiang Patentee after: Jiang Xin Address before: 150069 No. 2 Weihai Road, cottage economic and Technological Development Zone, Harbin, Heilongjiang Patentee before: Jiang Weishi |
|
CX01 | Expiry of patent term |
Granted publication date: 20060628 |
|
CX01 | Expiry of patent term |